Quinn Opportunity Partners’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,000
Closed -$32.2K 443
2024
Q4
$32.2K Hold
20,000
﹤0.01% 372
2024
Q3
$15.2K Hold
20,000
﹤0.01% 281
2024
Q2
$36K Sell
20,000
-10,000
-33% -$28.8K ﹤0.01% 272
2024
Q1
$143K Sell
30,000
-66,672
-69% -$234K 0.02% 220
2023
Q4
$280K Sell
96,672
-6,228
-6% -$9.82K 0.03% 186
2023
Q3
$139K Buy
+102,900
New +$180K 0.02% 209
2022
Q4
Sell
-21,144
Closed -$67.2K 200
2022
Q3
$67.2K Sell
21,144
-6,681
-24% -$24.3K 0.01% 177
2022
Q2
$89K Sell
27,825
-5,000
-15% -$14.5K 0.01% 185
2022
Q1
$99K Buy
+32,825
New +$111K ﹤0.01% 163
2021
Q1
Sell
-110,763
Closed -$1.23M 276
2020
Q4
$1.23M Sell
110,763
-168,906
-60% -$1.27M 0.1% 117
2020
Q3
$1.36M Sell
279,669
-217,100
-44% -$824K 0.14% 93
2020
Q2
$959K Buy
496,769
+20,000
+4% +$41K 0.12% 98
2020
Q1
$901K Buy
476,769
+322,778
+210% +$1.01M 0.14% 85
2019
Q4
$691K Buy
+153,991
New +$957K 0.08% 106

Other funds holding STIM

Quinn Opportunity Partners's STIM Position: Q1 2025 in Review

Quinn Opportunity Partners sold out of Neuronetics (STIM) in Q1 2025, closing a stake of 20,000 shares — an estimated $32.2K sold.

Quinn Opportunity Partners first reported a position in STIM in Q4 2019 and held it in 14 quarters. The position peaked at $1.36M in Q3 2020. 102 funds tracked by Wall St. Rank hold STIM as of Q1 2025.

  • Quinn Opportunity Partners reported no remaining Neuronetics position as of Q1 2025 after selling out during the quarter.
  • Quinn Opportunity Partners sold 20,000 Neuronetics shares in Q1 2025, an estimated $32.2K.
  • Quinn Opportunity Partners first reported a position in Neuronetics in Q4 2019 and held it in 14 quarters.
  • Quinn Opportunity Partners's Neuronetics position peaked at $1.36M in Q3 2020.
  • 102 funds tracked by Wall St. Rank held Neuronetics as of Q1 2025.

Based on Quinn Opportunity Partners's 13F filing for Q1 2025, filed 14 May 2025.